Frontiers in Medicine (May 2023)
An exome-wide study of renal operational tolerance
- Annick Massart,
- Annick Massart,
- Annick Massart,
- Richard Danger,
- Catharina Olsen,
- Catharina Olsen,
- Catharina Olsen,
- Mary J. Emond,
- Ondrej Viklicky,
- Valérie Jacquemin,
- Valérie Jacquemin,
- Julie Soblet,
- Julie Soblet,
- Julie Soblet,
- Sarah Duerinckx,
- Sarah Duerinckx,
- Didier Croes,
- Didier Croes,
- Didier Croes,
- Didier Croes,
- Camille Perazzolo,
- Petra Hruba,
- Dorien Daneels,
- Dorien Daneels,
- Dorien Daneels,
- Ben Caljon,
- Ben Caljon,
- Mehmet Sukru Sever,
- Julio Pascual,
- Julio Pascual,
- Marius Miglinas,
- the Renal Tolerance Investigators,
- Isabelle Pirson,
- Lidia Ghisdal,
- Guillaume Smits,
- Guillaume Smits,
- Magali Giral,
- Magali Giral,
- Magali Giral,
- Daniel Abramowicz,
- Marc Abramowicz,
- Marc Abramowicz,
- Marc Abramowicz,
- Sophie Brouard,
- Sophie Brouard,
- Sophie Brouard,
- Maria Aguilar Rodríguez,
- Friederike Bachmann,
- Rajendra Bahadur Shahi,
- Frederike Bemelman,
- Luboslav Bena,
- Luigi Biancone,
- Laura Braun,
- Klemens Budde,
- Alejandro Camargo-Salamanca,
- Katia Clemente,
- Hulya Colak,
- Adrian Covic,
- Jacques Degreve,
- Philippe Gatault,
- François Glowacki,
- Karine Hadaya,
- Marc Hazzan,
- Bénédicte Janbon,
- Christophe Legendre,
- Umberto Maggiore,
- Marius Miglinas,
- Anja Mühlfeld,
- Maarten Naesens,
- Christian Noël,
- Rainer Oberbauer,
- Evangeline Pillebout,
- Gian Benedetto Piredda,
- Francesco Pisani,
- Ana Ramírez Puga,
- Tomas Reischig,
- Francisco González-Roncero,
- Søren Schwartz Sørensen,
- Daniel Seron Micas,
- Nurhan Seyahi,
- Dimitrie Siriopol,
- Goce Spasovski,
- Jean-François Subra,
- Erik Teugels,
- Serhan Tuǧlular,
- Sonia Van Dooren,
- Catheline Vilain,
- Florence Villemain,
- Xavier Warling,
- Bruno Watschinger,
- Laurent Weekers
Affiliations
- Annick Massart
- Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
- Annick Massart
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Annick Massart
- Department of Nephrology, Antwerp University Hospital and Laboratory of Experimental Medicine, University of Antwerp, Antwerp, Belgium
- Richard Danger
- CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, CR2TI, UMR 1064, ITUN, Nantes, France
- Catharina Olsen
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Catharina Olsen
- Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium
- Catharina Olsen
- Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
- Mary J. Emond
- Department of Biostatistics, University of Washington, Seattle, WA, United States
- Ondrej Viklicky
- Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia
- Valérie Jacquemin
- Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
- Valérie Jacquemin
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Julie Soblet
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Julie Soblet
- Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium
- Julie Soblet
- 0Department of Genetics, Hôpital Universitaire des Enfants Reine Fabiola, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium
- Sarah Duerinckx
- Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
- Sarah Duerinckx
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Didier Croes
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Didier Croes
- Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium
- Didier Croes
- Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
- Didier Croes
- 1Center for Human Genetics, Clinique Universitaires Saint Luc, Brussels, Belgium
- Camille Perazzolo
- Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
- Petra Hruba
- Transplant Laboratory, Institute for Clinical and Experimental Medicine, Prague, Czechia
- Dorien Daneels
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Dorien Daneels
- Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium
- Dorien Daneels
- Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
- Ben Caljon
- Brussels Interuniversity Genomics High Throughput Core (BRIGHTcore), VUB-ULB, Brussels, Belgium
- Ben Caljon
- Center for Medical Genetics, Reproduction and Genetics, Reproduction Genetics and Regenerative Medicine, Vrije Universiteit Brussel, UZ Brussel, Brussels, Belgium
- Mehmet Sukru Sever
- 2Istanbul Tip Fakültesi, Istanbul School of Medicine, Internal Medicine, Nephrology, Istanbul, Türkiye
- Julio Pascual
- 3Department of Nephrology, Hospital del Mar, Institute Mar for Medical Research, Barcelona, Spain
- Julio Pascual
- 4Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain
- Marius Miglinas
- 5Nephrology Center, Santaros Klinikos, Medical Faculty, Vilnius University, Vilnius, Lithuania
- the Renal Tolerance Investigators
- Isabelle Pirson
- Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
- Lidia Ghisdal
- 6Department of Nephrology, Hospital Centre EpiCURA, Baudour, Belgium
- Guillaume Smits
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Guillaume Smits
- Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium
- Magali Giral
- CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, CR2TI, UMR 1064, ITUN, Nantes, France
- Magali Giral
- 7CHU Nantes, Centre d'Investigation Clinique en Biothérapie, Centre de Ressources Biologiques (CRB), Nantes, France
- Magali Giral
- 8LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
- Daniel Abramowicz
- Department of Nephrology, Antwerp University Hospital and Laboratory of Experimental Medicine, University of Antwerp, Antwerp, Belgium
- Marc Abramowicz
- Human Genetics Unit, Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles (ULB), Brussels, Belgium
- Marc Abramowicz
- Interuniversity Institute of Bioinformatics in Brussels (IB2), Université Libre de Bruxelles - Vrije Universiteit Brussel (ULB-VUB), Brussels, Belgium
- Marc Abramowicz
- 9Department of Genetic Medicine and Development, Faculty of Medicine, Université de Geneve, Geneva, Switzerland
- Sophie Brouard
- CHU Nantes, Nantes Université, INSERM, Center for Research in Transplantation and Translational Immunology, CR2TI, UMR 1064, ITUN, Nantes, France
- Sophie Brouard
- 7CHU Nantes, Centre d'Investigation Clinique en Biothérapie, Centre de Ressources Biologiques (CRB), Nantes, France
- Sophie Brouard
- 8LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
- Maria Aguilar Rodríguez
- Friederike Bachmann
- Rajendra Bahadur Shahi
- Frederike Bemelman
- Luboslav Bena
- Luigi Biancone
- Laura Braun
- Klemens Budde
- Alejandro Camargo-Salamanca
- Katia Clemente
- Hulya Colak
- Adrian Covic
- Jacques Degreve
- Philippe Gatault
- François Glowacki
- Karine Hadaya
- Marc Hazzan
- Bénédicte Janbon
- Christophe Legendre
- Umberto Maggiore
- Marius Miglinas
- Anja Mühlfeld
- Maarten Naesens
- Christian Noël
- Rainer Oberbauer
- Evangeline Pillebout
- Gian Benedetto Piredda
- Francesco Pisani
- Ana Ramírez Puga
- Tomas Reischig
- Francisco González-Roncero
- Søren Schwartz Sørensen
- Daniel Seron Micas
- Nurhan Seyahi
- Dimitrie Siriopol
- Goce Spasovski
- Jean-François Subra
- Erik Teugels
- Serhan Tuǧlular
- Sonia Van Dooren
- Catheline Vilain
- Florence Villemain
- Xavier Warling
- Bruno Watschinger
- Laurent Weekers
- DOI
- https://doi.org/10.3389/fmed.2022.976248
- Journal volume & issue
-
Vol. 9
Abstract
BackgroundRenal operational tolerance is a rare and beneficial state of prolonged renal allograft function in the absence of immunosuppression. The underlying mechanisms are unknown. We hypothesized that tolerance might be driven by inherited protein coding genetic variants with large effect, at least in some patients.MethodsWe set up a European survey of over 218,000 renal transplant recipients and collected DNAs from 40 transplant recipients who maintained good allograft function without immunosuppression for at least 1 year. We performed an exome-wide association study comparing the distribution of moderate to high impact variants in 36 tolerant patients, selected for genetic homogeneity using principal component analysis, and 192 controls, using an optimal sequence-kernel association test adjusted for small samples.ResultsWe identified rare variants of HOMER2 (3/36, FDR 0.0387), IQCH (5/36, FDR 0.0362), and LCN2 (3/36, FDR 0.102) in 10 tolerant patients vs. 0 controls. One patient carried a variant in both HOMER2 and LCN2. Furthermore, the three genes showed an identical variant in two patients each. The three genes are expressed at the primary cilium, a key structure in immune responses.ConclusionRare protein coding variants are associated with operational tolerance in a sizable portion of patients. Our findings have important implications for a better understanding of immune tolerance in transplantation and other fields of medicine.ClinicalTrials.gov, identifier: NCT05124444.
Keywords